📰 Michaelf Maclean News
Michaelf Maclean News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Michaelf Maclean. Real-time updates on events, politics, business and more.
May 18, 2024
Avidity Biosciences (NASDAQ:RNA – Get Free Report) issued its quarterly earnings results on Wednesday. The biotechnology company reported ($0.79) EPS for the quarter, beating the consensus estimate of ($0.81) by $0.02, Zacks reports. Avidity Biosciences had a negative net margin of 2,103.78% and a negative return on equity of 37.98%. The company had revenue of […]
May 16, 2024
Avidity Biosciences (NASDAQ:RNA – Get Free Report) released its quarterly earnings data on Wednesday. The biotechnology company reported ($0.79) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.81) by $0.02, Zacks reports. The company had revenue of $3.54 million during the quarter, compared to analyst estimates of $7.09 million. Avidity Biosciences had […]
May 2, 2024
Shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) have received an average recommendation of “Buy” from the six ratings firms that are covering the firm, Marketbeat reports. Six investment analysts have rated the stock with a buy rating. The average twelve-month price target among brokerages that have updated their coverage on the stock […]
January 26, 2024
Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) CFO Michael F. Maclean sold 1,616 shares of Avidity Biosciences stock in a transaction dated Monday, January 22nd. The shares were sold at an average price of $10.13, for a total value of $16,370.08. Following the completion of the transaction, the chief financial officer now directly owns […]